Crinetics Reviews Phase 1 CRN04894 Multiple-Ascending Dose Data


May 25, 2022 at 8:00 am ET

Crinetics management will discuss the positive results from the multiple-ascending dose cohorts of the CRN04894 Phase 1 clinical study that were reported this morning.